ArticleFrontiers in pediatrics2025

Case Report: Sustained biochemical remission following early initiation of odevixibat in an infant with monoallelic ABCB11 mutation and histologically confirmed PFIC2.

Thomas Kehler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.